"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Menactra Patient Information including How Should I Take
In this Article
- What is meningococcal conjugate vaccine (Menactra)?
- What are the possible side effects of meningococcal conjugate vaccine (Menactra)?
- What is the most important information I should know about meningococcal conjugate vaccine (Menactra)?
- What should I discuss with my healthcare provider before receiving meningococcal conjugate vaccine (Menactra)?
- How is meningococcal conjugate vaccine given (Menactra)?
- What happens if I miss a dose (Menactra)?
- What happens if I overdose (Menactra)?
- What should I avoid before or after getting meningococcal conjugate vaccine (Menactra)?
- What other drugs will affect meningococcal conjugate vaccine (Menactra)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving meningococcal conjugate vaccine (Menactra)?
You should not receive this vaccine if you have ever had an allergic reaction to a meningococcal or a diphtheria vaccine, if you are allergic to latex, or if you have a history of Guillain-Barre syndrome.
To make sure you can safely receive this vaccine, tell your doctor if you have any of these other conditions:
- a bleeding or blood clotting disorder, such as hemophilia;
- any condition that weakens the immune system (such as HIV, AIDS, or cancer); or
- if you are receiving steroids, chemotherapy, or radiation treatments.
If you have any of these conditions, you may not be able to receive meningococcal conjugate vaccine, or you may need to wait until your condition changes or you have completed your treatments.
FDA pregnancy category C. It is not known whether meningococcal conjugate vaccine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant soon after receiving this vaccine.
If you are pregnant, your name may be listed on a pregnancy registry. This is to track the outcome of the pregnancy and to evaluate any effects of meningococcal conjugate vaccine on the baby.
It is not known whether this vaccine passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
The Menactra brand of this vaccine should not be given to anyone younger than 9 months or older than 55 years of age. The Menveo brand should not be given to anyone younger than 2 years or older than 55 years of age.
How is meningococcal conjugate vaccine given (Menactra)?
This vaccine is injected into a muscle. You will receive this injection in a doctor's office or clinic setting.
Meningococcal conjugate vaccine is recommended in the following situations:
- for all children 9 months to 18 years old;
- for people who are in the military;
- for laboratory workers who are routinely exposed to meningococcal bacteria;
- for people who live in dormitories or other group housing; and
- for people who travel or live among certain populations where meningococcal outbreak is common.
This vaccine is usually given as a one-time injection to adults and children who are at least 2 years old. Unless your doctor's tells you otherwise, you will not need a booster vaccine.
In children younger than 2 years old, meningococcal conjugate vaccine is given in two doses. The first shot is usually given when the child is 9 months old. The booster shot is then given 3 months later.
Be sure your child receives all recommended doses of this vaccine. Your child may not be fully protected against disease if he or she does not receive the full series.
You can still receive a vaccine if you have a minor cold. In the case of a more severe illness with a fever or any type of infection, wait until you recover before receiving this vaccine.
Your doctor may recommend treating fever and pain with an aspirin free pain reliever such as acetaminophen (Tylenol) or ibuprofen (Motrin, Advil, and others) when the shot is given and for the next 24 hours. Follow the label directions or your doctor's instructions about how much of this medicine to give your child.
Additional Menactra Information
Menactra - User Reviews
Menactra User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.